Clinical Trials on Oligometastatic Lung Tumor in New Zealand
Total 9301 results
-
Proacta, IncorporatedCompletedUnspecified Adult Solid Tumor, Protocol SpecificNew Zealand
-
Roswell Park Cancer InstituteNeuroEndocrine Tumor Research Foundation (NETRF)RecruitingLung Atypical Carcinoid Tumor | Metastatic Pancreatic Neuroendocrine Tumor | Lung Typical Carcinoid TumorUnited States
-
ImmuneSensor Therapeutics Inc.RecruitingOligometastatic DiseaseUnited States
-
Middlemore Hospital, New ZealandUnknown
-
Proacta, IncorporatedTerminatedUnspecified Adult Solid Tumor, Protocol SpecificNew Zealand, United States
-
Novartis PharmaceuticalsTerminated
-
Athenex, Inc.PharmaEssentia; Zenith Technology Corporation LimitedCompletedSolid TumorNew Zealand, Taiwan, Australia
-
Memorial Sloan Kettering Cancer CenterCompletedOligometastatic Lung AdenocarcinomaUnited States
-
GlaxoSmithKlineCompleted
-
GlaxoSmithKlineCompleted
-
InSilico Medicine Hong Kong LimitedCompletedA Phase 1, Evaluate the Safety, Tolerability, and Pharmacokinetics of INS018_055 in Healthy SubjectsIdiopathic Pulmonary FibrosisNew Zealand
-
Australian & New Zealand Children's Haematology...National Health and Medical Research Council, Australia; Secura Bio, Inc.TerminatedRhabdoid Tumor | Atypical Teratoid/Rhabdoid Tumor | Malignant Rhabdoid Tumor | Recurrent Brain Tumor, ChildhoodAustralia, New Zealand, United States
-
University of Auckland, New ZealandTerminatedSmoking Cessation | Chronic Obstructive Pulmonary DiseaseNew Zealand
-
University of OtagoCompleted
-
Mylan Inc.Theravance BiopharmaCompleted
-
Mylan Inc.Theravance BiopharmaCompletedChronic Obstructive Pulmonary Disease, COPDNew Zealand
-
Proacta, IncorporatedCompletedUnspecified Adult Solid Tumor, Protocol SpecificNew Zealand, United States
-
Weill Medical College of Cornell UniversityMallinckrodtCompletedLung TumorUnited States
-
Waikato HospitalWaikato Hospital Research FundCompletedChronic Obstructive Pulmonary DiseaseNew Zealand
-
GlaxoSmithKlineCompleted
-
Athenex, Inc.PharmaEssentia; Zenith Technology Corporation LimitedCompletedSolid TumorNew Zealand, United Kingdom, Taiwan, Australia
-
Proacta, IncorporatedCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States, New Zealand
-
GlaxoSmithKlineCompleted
-
ReCode TherapeuticsRecruitingCystic FibrosisNew Zealand
-
Arcturus Therapeutics, Inc.Novotech CRORecruiting
-
Tufts Medical CenterTerminatedBrain Cancer | Choroid Plexus TumorsUnited States, Hungary, New Zealand, Germany
-
Bristol-Myers SquibbTerminatedTumorItaly, United States, New Zealand
-
Akesobio Australia Pty LtdCompletedCoronavirus Disease 2019 (COVID-19)New Zealand
-
Waikato HospitalWellington HospitalRecruitingGlioblastomaNew Zealand
-
University of OtagoHealth Research Council, New ZealandCompleted
-
Restorbio Inc.CompletedRespiratory Tract InfectionsNew Zealand
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingOligometastatic Malignant Solid NeoplasmUnited States
-
TaiRx, Inc.Active, not recruitingNeuroendocrine Tumors | Gastro-enteropancreatic Neuroendocrine Tumor | Neuroendocrine Carcinoma | Pancreatic Neuroendocrine Tumor | Lung Neuroendocrine NeoplasmTaiwan
-
Gitte Fredberg Persson MD PhDRecruitingSurgery | Oligometastatic Disease | Radiotherapy | Metastases | Stereotactic Radiation | Ablation TechniquesDenmark
-
Syneos HealthUS Specialty Formulations, LLCCompletedSARS-CoV-2 (COVID-19)New Zealand
-
Fisher and Paykel HealthcareMedical Research Institute of New Zealand; Alana HealthcareTerminatedChronic Obstructive Pulmonary Disease | COPDUnited States, New Zealand
-
GlaxoSmithKlineCompleted
-
Jiangsu Rec-Biotechnology Co., Ltd.Iqvia Pty LtdCompleted
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveAustralia, New Zealand
-
BeiGeneRecruitingSolid Tumor | Advanced Solid TumorUnited States, New Zealand, Australia, China
-
Robert RamirezAadi Bioscience, Inc.Terminated
-
Dicerna Pharmaceuticals, Inc.WithdrawnAlpha 1-Antitrypsin DeficiencyNew Zealand
-
Arrowhead PharmaceuticalsCompleted
-
VaxartCompletedSeasonal Influenza BNew Zealand